PubMed=14690602; DOI=10.1016/S1097-2765(03)00478-7
Zhu X.-D., Niedernhofer L.J., Kuster B., Mann M., Hoeijmakers J.H.J., de Lange T.
ERCC1/XPF removes the 3' overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes.
Mol. Cell 12:1489-1498(2003)

PubMed=17273966; DOI=10.1086/512486; PMCID=PMC1821117
Jaspers N.G.J., Raams A., Silengo M.C., Wijgers N., Niedernhofer L.J., Robinson A.R., Giglia-Mari G., Hoogstraten D., Kleijer W.J., Hoeijmakers J.H.J., Vermeulen W.
First reported patient with human ERCC1 deficiency has cerebro-oculo-facio-skeletal syndrome with a mild defect in nucleotide excision repair and severe developmental failure.
Am. J. Hum. Genet. 80:457-466(2007)

PubMed=30165384; DOI=10.1093/nar/gky774; PMCID=PMC6182131
Sabatella M., Theil A.F., Ribeiro-Silva C., Slyskova J., Thijssen K., Voskamp C., Lans H., Vermeulen W.
Repair protein persistence at DNA lesions characterizes XPF defect with Cockayne syndrome features.
Nucleic Acids Res. 46:9563-9577(2018)